<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 40-year-old male with Ph-positive <z:mp ids='MP_0005481'>CML</z:mp> underwent PBSC autografting after initial treatment with <z:chebi fb="0" ids="44423">hydroxyurea</z:chebi> and interferon </plain></SENT>
<SENT sid="1" pm="."><plain>Following autograft he remained in <z:hpo ids='HP_0011010'>chronic</z:hpo> phase with cytogenetic or molecular evidence of low levels of residual Ph-positive cells </plain></SENT>
<SENT sid="2" pm="."><plain>However, additional cytogenetic abnormalities, including t(3;21) typically seen in therapy-related <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> and <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> of <z:mp ids='MP_0005481'>CML</z:mp>, developed as an independent cell line following the autograft </plain></SENT>
<SENT sid="3" pm="."><plain>More than 4 years after the autograft, the patient remains in <z:hpo ids='HP_0011010'>chronic</z:hpo> phase with no evidence of accelerated phase or <z:e sem="disease" ids="C0005699" disease_type="Neoplastic Process" abbrv="">blast crisis</z:e> of <z:mp ids='MP_0005481'>CML</z:mp>, but with a concurrent <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>We report a case of <z:mp ids='MP_0005481'>CML</z:mp> who developed <z:e sem="disease" ids="C1292780" disease_type="Neoplastic Process" abbrv="">therapy-related MDS</z:e> following PBSC autograft while still remaining in <z:hpo ids='HP_0011010'>chronic</z:hpo> phase </plain></SENT>
</text></document>